7th Apr 2014 14:45
For immediate release | 7 April 2014 |
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
TR-1: Notification of Major Interest in Shares
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | Alliance Pharma plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | x | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | ||||
Other (please specify): |
| |||
3. Full name of person(s) subject to thenotification obligation: | Brown Shipley & Co Limited | |||
4. Full name of shareholder(s) (if different from 3.): | N/A | |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 04/04/2014 | |||
6. Date on which issuer notified: | 07/04/2014 | |||
7. Threshold(s) that is/are crossed orreached: | 3.01% | |||
8. Notified details: | |||||||||||
A: Voting rights attached to shares | |||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | |||||||
Direct | Direct | Indirect | Direct | Indirect | |||||||
7,815,845 | 7,815,845 | 7,941,145 | 7,941,145 | 3.01% | |||||||
GG0031030819 | |||||||||||
B: Qualifying Financial Instruments | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to
| % of voting rights
| |
| Nominal | Delta | ||||
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
7,815,845 | 3.01% |
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will ceaseto hold: | ||
12. Date on which proxy holder will cease to holdvoting rights: | ||
13. Additional information: | ||
14. Contact name: | Kieron Brooks | |
15. Contact telephone number: | 020 7282 3206 | |
Related Shares:
Alliance Pharma